 |
|
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
Børge G. Nordestgaard, MD, DMSc;
Marianne Benn, MD, PhD;
Peter Schnohr, MD;
Anne Tybjærg-Hansen, MD, DMSc
JAMA. 2007;298:299-308.
Context Elevated nonfasting triglycerides indicate the presence of remnant lipoproteins, which may promote atherosclerosis.
Objective To test the hypothesis that very high levels of nonfasting triglycerides predict myocardial infarction (MI), ischemic heart disease (IHD), and death.
Design, Setting, and Participants A prospective cohort study of 7587 women and 6394 men from the general population of Copenhagen, Denmark, aged 20 to 93 years, followed up from baseline (1976-1978) until 2004.
Main Outcome Measures Hazard ratios (HRs) for incident MI, IHD, and total death according to baseline nonfasting triglyceride level categories of 1 to 1.99 mmol/L (88.5-176.1 mg/dL), 2 to 2.99 mmol/L (177.0-264.6 mg/dL), 3 to 3.99 mmol/L (265.5-353.0 mg/dL), 4 to 4.99 mmol/L (354.0-441.6 mg/dL), and 5 mmol/L or more ( 442.5 mg/dL) vs triglyceride levels of less than 1 mmol/L (<88.5 mg/dL).
Results With increasing levels of nonfasting triglycerides, levels of remnant lipoprotein cholesterol increased. During a mean follow-up of 26 years, 1793 participants (691 women and 1102 men) developed MI, 3479 (1567 women and 1912 men) developed IHD, and 7818 (3731 women and 4087 men) died. For MI, among women, the age-adjusted HRs and multifactorially adjusted HRs (aHRs) for each respective category per 1-mmol/L increase in nonfasting triglyceride levels were 2.2 (aHR, 1.7), 4.4 (aHR, 2.5), 3.9 (aHR, 2.1), 5.1 (aHR, 2.4), and 16.8 (aHR, 5.4); for both, P for trend < .001. For MI, among men, the values were 1.6 (aHR, 1.4), 2.3 (aHR, 1.6), 3.6 (aHR, 2.3), 3.3 (aHR, 1.9), and 4.6 (aHR, 2.4); for both, P for trend < .001. For IHD, among women, the values were 1.7 (aHR, 1.4), 2.8 (aHR, 1.8), 3.0 (aHR, 1.8), 2.1 (aHR, 1.2), and 5.9 (aHR, 2.6); for both, P for trend < .001. For IHD, among men, the values were 1.3 (aHR, 1.1), 1.7 (aHR, 1.3), 2.1 (aHR, 1.3), 2.0 (aHR, 1.2), and 2.9 (aHR, 1.5); P for trend < .001 for age-adjusted and P for trend = .03 for multifactorially adjusted. For total death, among women, the values were 1.3 (aHR, 1.3), 1.7 (aHR, 1.6), 2.2 (aHR, 2.2), 2.2 (aHR, 1.9), and 4.3 (aHR, 3.3); for both, P for trend < .001. For total death, among men, the values were 1.3 (aHR, 1.2), 1.4 (aHR, 1.4), 1.7 (aHR, 1.5), 1.8 (aHR, 1.6), and 2.0 (aHR, 1.8); for both, P for trend < .001.
Conclusion In this general population cohort, elevated nonfasting triglyceride levels were associated with increased risk of MI, IHD, and death in men and women.
Author Affiliations: Department of Clinical Biochemistry, Herlev University Hospital, Herlev (Drs Nordestgaard and Benn), The Copenhagen City Heart Study, Bispebjerg University Hospital, Copenhagen (Drs Nordestgaard, Schnohr, and Tybjærg-Hansen), and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital (Dr Tybjærg-Hansen), University of Copenhagen, Copenhagen, Denmark.
RELATED LETTERS
Nonfasting Triglycerides and Cardiovascular Risk
William S. Yancy, Jr, Jeff S. Volek, and Eric C. Westman
JAMA. 2007;298(17):2004.
EXTRACT
| FULL TEXT
Nonfasting Triglycerides and Cardiovascular Risk
Konstantinos Tsarpalis
JAMA. 2007;298(17):2004-2005.
EXTRACT
| FULL TEXT
Nonfasting Triglycerides and Cardiovascular Risk—Reply
Børge G. Nordestgaard, Marianne Benn, and Anne Tybjærg-Hansen
JAMA. 2007;298(17):2005.
EXTRACT
| FULL TEXT
Nonfasting Triglycerides and Cardiovascular Risk—Reply
Paul M Ridker
JAMA. 2007;298(17):2005-2006.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
Sandeep Bansal, Julie E. Buring, Nader Rifai, Samia Mora, Frank M. Sacks, and Paul M Ridker
JAMA. 2007;298(3):309-316.
ABSTRACT
| FULL TEXT
Triglycerides and Risk for Coronary Heart Disease
Patrick E. McBride
JAMA. 2007;298(3):336-338.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Pollin et al.
Science 2008;322:1702-1705.
ABSTRACT
| FULL TEXT
Fasting and Postprandial Remnant-Like Particle Cholesterol Concentrations in Obese Participants Are Associated with Plasma Triglycerides, Insulin Resistance, and Body Fat Distribution
van Hees et al.
J. Nutr. 2008;138:2399-2405.
ABSTRACT
| FULL TEXT
Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
Freiberg et al.
JAMA 2008;300:2142-2152.
ABSTRACT
| FULL TEXT
Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction
Langsted et al.
Circulation 2008;118:2047-2056.
ABSTRACT
| FULL TEXT
ABCA1 Gene Mutations, HDL Cholesterol Levels, and Risk of Ischemic Heart Disease--Reply
Tybjaerg-Hansen et al.
JAMA 2008;300:1998-1998.
FULL TEXT
Accumulating short bouts of brisk walking reduces postprandial plasma triacylglycerol concentrations and resting blood pressure in healthy young men
Miyashita et al.
Am. J. Clin. Nutr. 2008;88:1225-1231.
ABSTRACT
| FULL TEXT
Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies
Livesey and Taylor
Am. J. Clin. Nutr. 2008;88:1419-1437.
ABSTRACT
| FULL TEXT
Superoxide Dismutase 3 Polymorphism Associated with Reduced Lung Function in Two Large Populations
Dahl et al.
Am. J. Respir. Crit. Care Med. 2008;178:906-912.
ABSTRACT
| FULL TEXT
Investigation and management of hypertriglyceridaemia
Ferns et al.
J. Clin. Pathol. 2008;61:1174-1183.
ABSTRACT
| FULL TEXT
Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Zacho et al.
NEJM 2008;359:1897-1908.
ABSTRACT
| FULL TEXT
Pentanucleotide Repeat Polymorphism, Lipoprotein(a) Levels, and Risk of Ischemic Heart Disease
Kamstrup et al.
J. Clin. Endocrinol. Metab. 2008;93:3769-3776.
ABSTRACT
| FULL TEXT
Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2008;118:993-1001.
ABSTRACT
| FULL TEXT
The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study
Svensson et al.
Nephrol Dial Transplant 2008;23:2918-2924.
ABSTRACT
| FULL TEXT
Apolipoprotein CIII and Atherosclerosis: Beyond Effects on Lipid Metabolism
Bobik
Circulation 2008;118:702-704.
FULL TEXT
Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients
Kallio et al.
Innate Immunity 2008;14:247-253.
ABSTRACT
An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients
Pullinger et al.
J. Lipid Res. 2008;49:1846-1854.
ABSTRACT
| FULL TEXT
Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study
Scheffer et al.
Clin. Chem. 2008;54:1325-1330.
ABSTRACT
| FULL TEXT
Gestational age and risk factors for cardiovascular disease: evidence from the 1958 British birth cohort followed to mid-life
Cooper et al.
Int J Epidemiol 2008;0:dyn154v1-dyn154.
ABSTRACT
| FULL TEXT
Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
Frikke-Schmidt et al.
JAMA 2008;299:2524-2532.
ABSTRACT
| FULL TEXT
Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
Despres et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1039-1049.
ABSTRACT
| FULL TEXT
Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study
Mozaffarian et al.
Arch Intern Med 2008;168:969-978.
ABSTRACT
| FULL TEXT
Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals
Stanhope et al.
Am. J. Clin. Nutr. 2008;87:1194-1203.
ABSTRACT
| FULL TEXT
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
Broadbent et al.
Hum Mol Genet 2008;17:806-814.
ABSTRACT
| FULL TEXT
Association of serum lipid indices with large artery atherosclerotic stroke
Bang et al.
Neurology 2008;70:841-847.
ABSTRACT
| FULL TEXT
The year in atherothrombosis.
Sanz et al.
J Am Coll Cardiol 2008;51:944-955.
FULL TEXT
Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance
Reyes et al.
J. Lipid Res. 2008;49:670-678.
ABSTRACT
| FULL TEXT
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Lund et al.
Eur J Endocrinol 2008;158:35-46.
ABSTRACT
| FULL TEXT
Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
Ridker
Clin. Chem. 2008;54:11-13.
FULL TEXT
Fasting versus Nonfasting Triglycerides: Implications for Laboratory Measurements
Warnick and Nakajima
Clin. Chem. 2008;54:14-16.
FULL TEXT
Nonfasting Triglycerides and Cardiovascular Risk
Yancy et al.
JAMA 2007;298:2004-2004.
FULL TEXT
Nonfasting Triglycerides and Cardiovascular Risk Reply
Ridker
JAMA 2007;298:2005-2006.
FULL TEXT
Triglycerides and Coronary Heart Disease Revisited (Again)
Criqui
ANN INTERN MED 2007;147:425-427.
FULL TEXT
Hypertriglyceridemia
Brunzell
NEJM 2007;357:1009-1017.
FULL TEXT
Are Nonfasting Better Than Fasting Triglyceride Levels at Predicting Cardiac Events?
Journal Watch Cardiology 2007;2007:1-1.
FULL TEXT
Triglycerides and Risk for Coronary Heart Disease
McBride
JAMA 2007;298:336-338.
FULL TEXT
|
